Reactive infectious mucocutaneous eruption following <scp>COVID</scp>‐19 in an adolescent boy: Case report and review of the literature
Ayisha Mahama, Priscilla Ly Kojder, Quinn Thibodeaux, J. Ruth
Abstract
Reactive infectious mucocutaneous eruption (RIME) is a mucosal-predominant eruption that usually affects two or more mucosal sites. We present a case of RIME secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and provide a brief review of the literature with a focus on the natural history and response to treatment. This entity may require inpatient management and systemic corticosteroids for symptom control in the pediatric population.
Topics & Concepts
MedicineMucocutaneous zoneCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyNatural history2019-20 coronavirus outbreakPopulationDermatologyPediatricsInfectious disease (medical specialty)VirologyPathologyDiseaseInternal medicineOutbreakEnvironmental healthDermatological and COVID-19 studiesStreptococcal Infections and TreatmentsDermatology and Skin Diseases